<DOC>
	<DOCNO>NCT00193466</DOCNO>
	<brief_summary>In multicenter trial , investigate use fludarabine plus rituximab , follow Campath-1H , previously untreated patient CLL/SLL . Patients elderly , consider unlikely tolerate combination therapy well , receive single agent rituximab follow Campath-1H .</brief_summary>
	<brief_title>Rituximab Fludarabine Followed CAMPATH-1H Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma</brief_title>
	<detailed_description>Upon determination eligibility , patient receive : Fludarabine + Rituximab + CAMPATH-1H Patients judge investigator candidate fludarabine due advanced age , marginal performance status coexistent medical condition receive rituximab alone follow CAMPATH-1H .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Alemtuzumab</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>To include study , must meet following criterion : Histologically proven Bcell CLL/SLL Positive stain CD20 antigen No systemic chemotherapy . Measurable evaluable disease Able perform activity daily live minimal assistance Age &gt; 18 year Life expectancy &gt; 12 week Adequate liver kidney function Must accessible treatment followup Must give write informed consent prior enter study . You participate study follow apply : Female pregnant lactate Unstabilized active infection basis neutropenia History previous severe opportunistic infection Serious underlie medical condition Central nervous system involvement History neoplasm , either active treat within five year Please note : There additional inclusion/exclusion criterion . The study center determine meet criterion . If qualify trial , study personnel explain reason . If qualify , study personnel explain trial detail answer question may .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>